Reach Us +44-1235-425476
Sarcoidosis and Obstructive Sleep Apnea: Yet another Overlap Syndrome? | OMICS International
ISSN: 2161-105X
Journal of Pulmonary & Respiratory Medicine

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Sarcoidosis and Obstructive Sleep Apnea: Yet another Overlap Syndrome?

Andre Holmes, Charlie Strange and Chitra Lal*

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, CSB 812, MSC 630, Charleston, SC 29425, USA

*Corresponding Author:
Dr. Chitra Lal
MD, D-ABSM, FCCP, Assistant Professor of Medicine
Medical Division of Pulmonary, Critical Care
Allergy and Sleep Medicine, Medical University of South Carolina
96 Jonathan Lucas Street, CSB 812
MSC 630, Charleston, SC 29425, USA
Tel: (843)792-7776
E-mail: [email protected],[email protected]

Received date: March 20, 2012; Accepted date: March 22, 2012; Published March 24, 2012

Citation: Holmes A, Strange C, Lal C (2012) Sarcoidosis and Obstructive Sleep Apnea: Yet another Overlap Syndrome?. J Pulmonar Respirat Med 2:e113. doi:10.4172/2161-105X.1000e113

Copyright: © 2012 Holmes A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Pulmonary & Respiratory Medicine

Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that can affect any organ system in the body. Commonly, it involves the lungs and can present in various stages. Sarcoidosis may involve the upper respiratory tract in 2%-6% of patients [1].

Obstructive Sleep Apnea Syndrome (OSAS) is a common disorder which is often under diagnosed. Since OSAS is a major health problem with significant long term sequelae, there is a major interest in the prevention, early diagnosis, and adequate treatment of OSAS. Since the pathogenesis of OSAS is incompletely defined, rare diseases such as sarcoidosis may provide insight into OSAS causation, if there is a link between untreated sarcoidosis and OSAS development. Potential pathogenic mechanisms would include upper airway involvement by granulomatous inflammation, hypotonicity of the upper airway due to sarcoid myopathy or neuropathy or another unrecognized mechanism.

Sarcoid lesions in the upper airway can consist of large granulomatous lesions and nodules of the epiglottis and other supraglottic structures. Adhesions due to chronic inflammation and scarring may occur [2]. An epidemiologic study of 736 sarcoid patients in the United States revealed involvement of the ear, nose and throat in 2.3% of patients [3]. Visualization of the oropharyngeal cavity with a laryngoscope may reveal epiglottic thickening and granularity, granulomatous masses, and infiltrative sarcoid nodules of the epiglottis, aryepiglottic folds, and false cords [4]. Occasionally, laryngeal sarcoid can lead to progressive lifethreatening airway obstruction. The incidence of laryngeal sarcoidosis is estimated at 1.2% [5]. There are case reports of the occurrence of OSAS due to laryngeal involvement with sarcoidosis [6].

OSAS has been reported to occur with a higher frequency in sarcoid patients, with one study reporting a prevalence of 17% as opposed to 3% in the non-sarcoid control group [7]. The exact reasons for a higher prevalence of OSAS in sarcoidosis are not fully understood; however, any of the mechanisms described above could predispose to the development of OSAS or worsen pre-existing OSAS. Other theories suggest that obesity resulting from excessive corticosteroid use increase neck circumference and narrow the upper airway. Potential associations with lupus pernio and neurosarcoidosis have been correlated with a higher prevalence of OSAS [7].

Although the impact of OSAS in sarcoidosis patients remains to be defined, both diseases can cause fatigue [8,9]. Since OSAS related fatigue is treated with continuous positive airway pressure (CPAP) and sarcoid related fatigue may require immunosuppressive therapy, it is important to differentiate these two conditions. The overlap between sarcoidosis and OSAS could also have significant adverse effects on lung physiology. Since the nocturnal hypoxemia resulting from this overlap syndrome might be worse than hypoxemia from either disease alone, the impact on cardiovascular co-morbidities could be exponentially higher. These detrimental effects of sleep-related hypoventilation and hypoxemia may include pulmonary hypertension, cerebrovascular disease with associated neurocognitive deficits and coronary artery disease.

Management of obesity is an important aspect of pulmonary practice. As a specialty that uses a disproportionate share of corticosteroids, we have a duty to be sensitive to the possibility of OSAS development. While future studies will be required to define if an overlap syndrome between sarcoidosis and OSAS exists independent of corticosteroid induced obesity, the possibility exists that patients will be harmed if OSAS is left untreated. Future studies should target the possible pathogenetic mechanisms that underlie the relationship between OSAS and sarcoidosis. A better understanding of this overlap syndrome might also help in the evolution of new treatment modalities and therapeutic interventions for both disorders.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 13641
  • [From(publication date):
    June-2012 - Oct 20, 2018]
  • Breakdown by view type
  • HTML page views : 9819
  • PDF downloads : 3822

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version